Figure 2. A Model for Incorporating Systematic Molecular Phenotyping into Emergency Care.

There are multiple potential sources for baseline systematic molecular phenotyping data to be entered into an acute care patient’s electronic health record. During the visit itself, clinical data can be combined with this data to help provide complex decision support. In the future, with more rapid turnaround times, systematic molecular phenotyping might be performed primarily in the ED and incorporated into such systems. Alternatively, patients may arrive with portably stored systematic molecular phenotyping data, or targeted testing of genotypes might be posited based on the patient’s clinical scenario. The results of any testing done in the acute care setting would be retained for future visits, or a patient might have systematic molecular phenotyping done as part of an ED-based public health intervention and stored for future use.